Showing results (71-80 of 120) with videos related to
Sort By:
Pageof 12
Blood|November 19, 2008
Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemiaSteven P Treon, Andrew R Branagan, Leukothea Ioakimidis, et al.Immunotherapy|July 20, 2010
Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a phase I clinical studyLisbeth Barkholt, Evren Alici, Reka Conrad, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
BCL-2/IgH polymerase chain reaction status at the end of induction treatment is not predictive for progression-free survival in relapsed/resistant follicular lymphoma: results of a prospective randomized EORTC 20981 phase III intergroup studyMarinus H J van Oers, Evelyn Tönnissen, Martine Van Glabbeke, et al.Blood|July 29, 2006
Rituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trialMarinus H J van Oers, Richard Klasa, Robert E Marcus, et al.Cancer Immunology Research|January 20, 2019
TIGIT and PD-1 Mark Intratumoral T Cells with Reduced Effector Function in B-cell Non-Hodgkin LymphomaSarah E Josefsson, Klaus Beiske, Yngvild N Blaker, et al.British Journal of Haematology|February 4, 2020
Prognostic implications of the microenvironment for follicular lymphoma under immunomodulation therapyThomas Menter, Alexandar Tzankov, Emanuele Zucca, et al.Clinical Lymphoma, Myeloma & Leukemia|August 31, 2022
Factors Affecting the Clinical Course of Follicular Lymphoma: A Multistate Survival Analysis Using Individual Patient Data from Eight Multicenter Randomized Clinical TrialsJesse G Dixon, Çağlar Çağlayan, Dai Chihara, et al.Haematologica|November 24, 2018
First-line therapy in chronic lymphocytic leukemia: a Swedish nation-wide real-world study on 1053 consecutive patients treated between 2007 and 2013Sandra Eketorp Sylvan, Anna Asklid, Hemming Johansson, et al.Seminars in Hematology|May 25, 2025
Report of Consensus Panel 2 from the 12th International Workshop on the management of Bing-Neel syndrome in patients with Waldenstrom's MacroglobulinemiaShayna Sarosiek, Anne-Marie L Becking, Andrew Branagan, et al.Haematologica|November 11, 2003
Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantationJohannes Schetelig, Sebastian Fetscher, Albrecht Reichle, et al.Pageof 12